PORTLAND, KS, UNITED STATES, February 6, 2025 /EINPresswire / -- Rise in incidences of fungal and nosocomial infections, surge in initiatives by public and private organizations to spread awareness ...
The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.